chr6-152350730-T-G

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_182961.4(SYNE1):ā€‹c.11621A>Cā€‹(p.Lys3874Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0262 in 1,614,084 control chromosomes in the GnomAD database, including 1,203 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.025 ( 99 hom., cov: 32)
Exomes š‘“: 0.026 ( 1104 hom. )

Consequence

SYNE1
NM_182961.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.447
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SYNE1. . Gene score misZ -0.29069 (greater than the threshold 3.09). Trascript score misZ 3.2909 (greater than threshold 3.09). GenCC has associacion of gene with autosomal recessive ataxia, Beauce type, autosomal recessive myogenic arthrogryposis multiplex congenita, Emery-Dreifuss muscular dystrophy 4, autosomal dominant, arthrogryposis multiplex congenita 3, myogenic type, autosomal dominant Emery-Dreifuss muscular dystrophy.
BP4
Computational evidence support a benign effect (MetaRNN=0.0018830597).
BP6
Variant 6-152350730-T-G is Benign according to our data. Variant chr6-152350730-T-G is described in ClinVar as [Benign]. Clinvar id is 130394.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-152350730-T-G is described in Lovd as [Likely_benign]. Variant chr6-152350730-T-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.121 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SYNE1NM_182961.4 linkuse as main transcriptc.11621A>C p.Lys3874Thr missense_variant 71/146 ENST00000367255.10 NP_892006.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SYNE1ENST00000367255.10 linkuse as main transcriptc.11621A>C p.Lys3874Thr missense_variant 71/1461 NM_182961.4 ENSP00000356224.5 Q8NF91-1
SYNE1ENST00000423061.6 linkuse as main transcriptc.11576A>C p.Lys3859Thr missense_variant 71/1461 ENSP00000396024.1 A0A0C4DG40
SYNE1ENST00000471834.1 linkuse as main transcriptn.4759A>C non_coding_transcript_exon_variant 14/191

Frequencies

GnomAD3 genomes
AF:
0.0248
AC:
3765
AN:
152102
Hom.:
97
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0105
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0429
Gnomad ASJ
AF:
0.0124
Gnomad EAS
AF:
0.130
Gnomad SAS
AF:
0.0719
Gnomad FIN
AF:
0.0206
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0196
Gnomad OTH
AF:
0.0249
GnomAD3 exomes
AF:
0.0366
AC:
9203
AN:
251310
Hom.:
338
AF XY:
0.0376
AC XY:
5103
AN XY:
135826
show subpopulations
Gnomad AFR exome
AF:
0.00941
Gnomad AMR exome
AF:
0.0410
Gnomad ASJ exome
AF:
0.0144
Gnomad EAS exome
AF:
0.127
Gnomad SAS exome
AF:
0.0752
Gnomad FIN exome
AF:
0.0225
Gnomad NFE exome
AF:
0.0190
Gnomad OTH exome
AF:
0.0311
GnomAD4 exome
AF:
0.0263
AC:
38512
AN:
1461864
Hom.:
1104
Cov.:
33
AF XY:
0.0276
AC XY:
20051
AN XY:
727228
show subpopulations
Gnomad4 AFR exome
AF:
0.00956
Gnomad4 AMR exome
AF:
0.0406
Gnomad4 ASJ exome
AF:
0.0138
Gnomad4 EAS exome
AF:
0.160
Gnomad4 SAS exome
AF:
0.0707
Gnomad4 FIN exome
AF:
0.0215
Gnomad4 NFE exome
AF:
0.0185
Gnomad4 OTH exome
AF:
0.0287
GnomAD4 genome
AF:
0.0247
AC:
3767
AN:
152220
Hom.:
99
Cov.:
32
AF XY:
0.0260
AC XY:
1936
AN XY:
74430
show subpopulations
Gnomad4 AFR
AF:
0.0104
Gnomad4 AMR
AF:
0.0431
Gnomad4 ASJ
AF:
0.0124
Gnomad4 EAS
AF:
0.129
Gnomad4 SAS
AF:
0.0722
Gnomad4 FIN
AF:
0.0206
Gnomad4 NFE
AF:
0.0196
Gnomad4 OTH
AF:
0.0270
Alfa
AF:
0.0228
Hom.:
207
Bravo
AF:
0.0254
TwinsUK
AF:
0.0200
AC:
74
ALSPAC
AF:
0.0208
AC:
80
ESP6500AA
AF:
0.00749
AC:
33
ESP6500EA
AF:
0.0201
AC:
173
ExAC
AF:
0.0364
AC:
4418
Asia WGS
AF:
0.0910
AC:
315
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 23, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
not provided Benign:2
Likely benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Autosomal recessive ataxia, Beauce type Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
9.8
DANN
Benign
0.95
DEOGEN2
Benign
0.14
T;.;T
Eigen
Benign
-0.50
Eigen_PC
Benign
-0.39
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.69
T;T;T
MetaRNN
Benign
0.0019
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.6
L;.;.
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-1.3
N;.;N
REVEL
Benign
0.016
Sift
Benign
0.10
T;.;T
Sift4G
Benign
0.10
T;T;T
Polyphen
0.050
B;.;.
Vest4
0.16
MPC
0.16
ClinPred
0.0046
T
GERP RS
2.3
Varity_R
0.095
gMVP
0.071

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs13210127; hg19: chr6-152671865; API